01—Abstract
Summary
Summary of the 8-K filed April 29, 2024. Cited figures are marked; the original filing is the authoritative source.
Johnson & Johnson (JNJ) filed an 8-K on April 29, 2024, detailing key governance and shareholder meeting outcomes from their 2024 Annual Meeting held on April 25, 2024.
The most significant corporate action was the adoption of amended and restated by-laws, which introduce updated procedures for shareholder actions, including calling special meetings and submitting director nominations or proposals. These changes aim to align with current regulatory standards, such as universal proxy rules, and clarify existing corporate governance practices. Furthermore, the filing provides the final voting results from the Annual Meeting.
Shareholders overwhelmingly elected all 13 director nominees, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2024. Notably, a shareholder proposal requesting a report on gender-based compensation gaps and associated risks was not approved.
02—Key points
Key Highlights
- Johnson & Johnson adopted Amended and Restated By-Laws effective April 25, 2024, updating procedural and informational requirements for shareholder actions.
- Key by-law updates include enhanced requirements for shareholders to call special meetings and submit director nominations/proposals, incorporating "universal proxy" rules.
- All 13 director nominees presented at the 2024 Annual Meeting of Shareholders were elected by shareholders.
- Shareholders approved the company's executive compensation philosophy, policies, and procedures on an advisory basis (Say on Pay).
- The appointment of PricewaterhouseCoopers LLP as JNJ's independent registered public accounting firm for fiscal year 2024 was ratified.
- A shareholder proposal concerning gender-based compensation gaps and associated risks did not receive majority approval.
03—Questions
Frequently Asked Questions
What are the key changes to Johnson & Johnson's by-laws?
The Amended and Restated By-Laws update procedures for shareholders requesting special meetings and submitting nominations/proposals. They also clarify rules for meeting conduct, director nominations (including "proxy access" and "universal proxy" rules), and update director/officer indemnification provisions.
How did shareholders vote on the election of directors?
Shareholders overwhelmingly voted to elect all 13 director nominees named in the 2024 Proxy Statement to the Board of Directors. The voting results show substantial 'For' votes across all nominees.
What was the outcome of the advisory vote on executive compensation (Say on Pay)?
The advisory vote to approve the executive compensation philosophy, policies, and procedures, as well as the compensation of named executive officers, was approved by shareholders.
Was the shareholder proposal regarding gender-based compensation gaps approved?
No, the shareholder proposal requesting a report on gender-based compensation gaps and associated risks did not receive majority approval from shareholders. The voting results show a significant majority voted against this proposal.
04—Continue